產品詳情
簡單介紹：
Anti-BIN2抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-BIN2抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-BIN2
Cat. Number:
Anti-BIN2抗體KL-9727R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BAR proteins are characterized by a common N-terminal BAR (bin, amphiphysin and Rvs161/167) domain and are recognized asAnti-BIN2抗體adaptor proteins that are involved in many cellular processes. BIN1 and BIN2 are BAR proteins that share 61% sequence similarity. BIN1 (Bridging integrator 1) is a ubiquitously expressed regulatory protein for synaptic vesicle endocytosis. BIN1 also interacts with the transcription factors c-Myc and MyoD, potentially functioning as a tumor suppressor. BIN2, also known as Breast cancer-associated protein 1, is a 565 amino acid protein that interacts with BIN1. In contrast to BIN1, BIN2 lacks tumor suppressor features as well as a c-Myc interacting region. BIN2 shows preferred expression in tissues of hematopoietic origin, with high levels found in spleen, thymus, colon, placenta, lymphoid and granulocytic cells. There are two isoforms of BIN2 that are produced Anti-BIN2抗體as a result of alternative splicing events.
Also known as:
BIN2; BIN2_HUMAN; BRAP 1; Breast cancer associated protein BRAP1; Breast cancer-associated protein 1; Bridging integrator 2.Anti-BIN2抗體
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BIN2/BRAP1.
●
Predicted Molecular Weight: 62kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working dilutions mustAnti-BIN2抗體be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions mustAnti-BIN2抗體be determined by the end user.
kl119Po01 CD40配體(CD40L)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 40 Ligand (CD40L)
kl119Ra01 CD40配體(CD40L)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 40 Ligand (CD40L)
kl119Si01 CD40配體(CD40L)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 40 Ligand (CD40L)
kl120Bo01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Ca01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Cp01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Eq01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Ga01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Hu01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Mu01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl120Ra01 干細胞因子(SCF)多克隆抗體 Polyclonal Antibody to Stem Cell Factor (SCF)
kl121Hu01 干細胞因子受體(SCFR)多克隆抗體 Polyclonal Antibody to Stem Cell Factor Receptor (SCFR)
kl121Mu01 干細胞因子受體(SCFR)多克隆抗體 Polyclonal Antibody to Stem Cell Factor Receptor (SCFR)
kl122Fi01 基質細胞衍生因子1(SDF1)多克隆抗體 Polyclonal Antibody to Stromal Cell Derived Factor 1 (SDF1)
kl122Hu01 基質細胞衍生因子1(SDF1)多克隆抗體 Polyclonal Antibody to Stromal Cell Derived Factor 1 (SDF1)
kl122Mu01 基質細胞衍生因子1(SDF1)多克隆抗體 Polyclonal Antibody to Stromal Cell Derived Factor 1 (SDF1)
kl122Ra01 基質細胞衍生因子1(SDF1)多克隆抗體 Polyclonal Antibody to Stromal Cell Derived Factor 1 (SDF1)
kl123Cp01 轉化生長因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl123Po01 轉化生長因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl123Rb51 轉化生長因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl123Si01 轉化生長因子α(TGFα)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Alpha (TGFa)
kl124Fi01 轉化生長因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Si01 轉化生長因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
